<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337715/" ref="ordinalpos=2451&amp;ncbi_uid=3969652&amp;link_uid=PMC3337715" image-link="/pmc/articles/PMC3337715/figure/F1/" class="imagepopup">Figure 1. <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">pathway</span> of PI 3-kinase, Akt and mTOR.  From: Phosphoinositide-3 kinase <span class="highlight" style="background-color:">signaling</span> in cardiac hypertrophy and heart failure. </a></div><br /><div class="p4l_captionBody">Signaling pathways are depicted schematically. FKBP: FK506-binding protein, GLUT: glucose transporter, GPCR: G protein-coupled receptor, GSK: Glycogen synthase kinase, IGF: Insulin-like growth factor, PDK: phosphoinositide-dependent kinase, PI3K: phosphoinositide 3-kinase, PtdIns: phosphatidylinositol, PTEN: phosphatase and tensin homolog deleted on chromosome ten, p70S6K: p70S6 kinase, TSC: tuberous sclerosis complex, eIF4: eukaryotic initiation factor 4.</div></div>